1. Chakraborty S, Vimalnath KV, Chakravarty R, Sarma HD, Dash A. Multidose formulation of ready-to-use (177)Lu-PSMA-617 in a centralized radiopharmacy set-up. Appl Radiat Isot. 2018;139:91–7.
2. Coenen HH, Gee AD, Adam M, Antoni G, Cutler CS, Fujibayashi Y, et al. Open letter to journal editors on: International consensus radiochemistry nomenclature guidelines. Am J Nucl Med Mol Imaging. 2018;8(1):70–2.
3. de Blois E, Chan HS, de Zanger R, Breeman WAP. Effectiveness of quenchers to reduce radiolysis of In-111- or Lu-177-labelled methionine containing gastrin and bombesin analogues. J Labelled Comp Radiopharm. 2013;56:S210–S.
4. de Blois E, Chan HS, de Zanger R, Konijnenberg M, Breeman WA. Application of single-vial ready-for-use formulation of 111In- or 177Lu-labelled somatostatin analogs. Appl Radiat Isot. 2014;85:28–33.
5. Decristoforo C, Penuelas I, Patt M, Todde S. European regulations for the introduction of novel radiopharmaceuticals in the clinical setting. Q J Nucl Med Mol Imaging. 2017;61(2):135–44.